Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance infections. If solutions aren’t found and put in place, 10 million people could die from antibiotic resistance-related diseases by ... [Read]
Why Psychedelics Could Soon Replace Antidepressants
Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety medications available, treatment resistance occurs in roughly 30% of patients. Anxiety ... [Read]
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic compound being used as an alternative treatment. The Sonoran desert toad is the only animal on earth ... [Read]
Pharmacy Giant Files Patent to Join the Metaverse
The Metaverse could soon have its own pharmacy after CVS revealed its plans to sell virtual goods and provide healthcare services in the virtual world. As CNBC reported on March 4, the pharmacy giant filed ... [Read]
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health ... [Read]
MCK Stock Gains on Reports of $18 Billion Opioid Settlement
MCK stock is up nearly 5% amid reports that McKesson (NYSE:MCK), along with AmerisourceBergen (NYSE:ABC) and Cardinal Health (NYSE:CAH), is considering an $18 billion USD settlement to end lawsuits relating to its role in contributing to ... [Read]
ILMN Stock Falls 15%: Illumina Spooks Investors by Slashing Earnings
ILMN stock is taking a major hit in Friday’s trading session after the DNA sequencing company Illumina, Inc. (NASDAQ:ILMN) stated that its Q2 2019 revenue will miss projections because of challenges with its direct-to-consumer genomic ... [Read]
Aurora Cannabis Enters Agreement With Heinrich Klenk GmbH & Co.
Vancouver-based Aurora Cannabis (TSX:ACB) has entered into an agreement, through its subsidiary Pedanios, with one of Europe’s largest medicinal plant company Heinrich Klenk GmbH & Co. KG. Heinrich Klenk, whose products are available in over 25,000 pharmacies ... [Read]
7 Medical Advancements in 2017 Worth Investing In
1. Tricorders In Star Trek: The Original Series, Dr. McCoy — nicknamed “Bones” — carried around a device called a tricorder that could record and relay medical information. This cool fictional technology is on its ... [Read]